RegenoCELL Therapeutics, Inc.
| OTC Markets: RCLL
RegenoCELL Therapeutics, Inc. is a development stage company, which is engaged in manufacturing and selling stem cell therapy product used to treat congestive heart failure and peripheral artery disease. The company utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. Its stem cells enable the normal development, and the regeneration and repair of damaged tissues through the ability to differentiate into the type of cell needed for growth or repair. The company was formerly known as Good Buddy's Coffee Express, Inc. and changed its name to RegenoCELL Therapeutics, Inc. in July 2008. RegenoCELL Therapeutics was founded on February 1, 2002 by Scott Massey and is headquartered in Natick, MA.